When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Dubin-Johnson syndrome

Última revisão: 13 Jan 2026
Última atualização: 10 Dec 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • intermittent jaundice
  • lack of pruritus
Detalhes completos

Outros fatores diagnósticos

  • illness, infection, or stress
  • pregnancy-triggered jaundice
  • medication-triggered jaundice
  • abdominal pain
  • fatigue
  • hepatomegaly
Detalhes completos

Fatores de risco

  • family history
  • age 10 to 30 years
  • Iranian Jewish or Moroccan Jewish ethnicity
  • male sex
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • serum bilirubin
  • serum alkaline phosphatase
  • serum liver aminotransferases (aspartate aminotransferase and alanine aminotransferase)
  • serum albumin
  • serum gamma-glutamyl transferase
  • serum bile acids
  • clotting profile
Detalhes completos

Investigações a serem consideradas

  • urinary coproporphyrin I to III ratio
  • 99mTc hepatobiliary imino-diacetic acid (HIDA) scan (cholescintigraphy)
  • liver biopsy
  • mutational analysis of the ABCC2 gene
Detalhes completos

Novos exames

  • urinary leukotriene metabolites

Algoritmo de tratamento

AGUDA

all patients

Colaboradores

Autores

Anil Dhawan, MBBS, MD, FRCPCH
Anil Dhawan

Professor of Paediatric Hepatology

King's College Hospital

London

UK

Declarações

AD declares he has no competing interests.

Tracy A.F. Coelho, MBBS, DCH, MRCPCH, PhD
Tracy A.F. Coelho

Consultant Paediatric Gastroenterologist

University Hospital Southampton

Southampton

UK

Disclosures

TAFC declares that he has no competing interests.

Peer reviewers

John T. Jenkins, MB, CHB, FRCP

Consultant Surgeon

St. Mark's Hospital

London

UK

Disclosures

JTJ declares that he has no competing interests.

Nancy Reau, MD

Assistant Professor of Medicine

University of Chicago

Center for Liver Disease

Chicago

IL

Disclosures

NR has received reimbursement for speaking for Gilead, maker of Viread and Hepsera, and BMS, maker of Baraclude.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Dubin IN, Johnson FB. Chronic idiopathic jaundice with unidentified pigment in the liver cells: a new clinicopathologic entity with report of 12 cases. Medicine. 1954 Sep;33(3):155-97. Abstract

Dubin IN. Chronic idiopathic jaundice: a review of 50 cases. Am J Med. 1958 Feb;24(2):268-92. Abstract

Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017 Jan;112(1):18-35. Abstract

Machida I, Wakusawa S, Sanae F, et al. Mutational analysis of the MRP2 gene and long-term follow-up of Dubin-Johnson syndrome in Japan. J Gastroenterol. 2005 Apr;40(4):366-70. Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Use of this content is subject to our disclaimer